These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparing antibody and small-molecule therapies for cancer. Imai K; Takaoka A Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325 [TBL] [Abstract][Full Text] [Related]
6. New vinca alkaloids and related compounds. Budman DR Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165 [TBL] [Abstract][Full Text] [Related]
7. Looking for a miracle. Marchant J New Sci; 2000 Jun; 166(2244):16-7. PubMed ID: 11902203 [No Abstract] [Full Text] [Related]
8. Part II: management of resistance to imatinib in chronic myeloid leukaemia. Apperley JF Lancet Oncol; 2007 Dec; 8(12):1116-1128. PubMed ID: 18054881 [TBL] [Abstract][Full Text] [Related]
9. BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia. Salesse S; Verfaillie CM Oncogene; 2002 Dec; 21(56):8547-59. PubMed ID: 12476301 [No Abstract] [Full Text] [Related]
10. [Target-oriented tumor therapy -- proof of the principle]. Gastl G; Hiddemann W Dtsch Med Wochenschr; 2004 Oct; 129(40):2093. PubMed ID: 15455299 [No Abstract] [Full Text] [Related]
11. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia. Carella AM Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645 [No Abstract] [Full Text] [Related]
12. Prospects of Utilizing Computational Techniques for the Treatment of Human Diseases. Nayarisseri A Curr Top Med Chem; 2019; 19(13):1071-1074. PubMed ID: 31490742 [No Abstract] [Full Text] [Related]
14. [Chronic myelogenous leukemia]. Yoshida C Rinsho Ketsueki; 2013 Jan; 54(1):61-70. PubMed ID: 23391648 [No Abstract] [Full Text] [Related]
15. Treatment of refractory immune cytopenias in the 21st century--how safe is rituximab? Ravindranath Y Am J Hematol; 2005 Sep; 80(1):92-3. PubMed ID: 16138348 [No Abstract] [Full Text] [Related]
16. Targeted chemotherapy: chronic myelogenous leukemia as a model. Sharifi N; Steinman RA J Mol Med (Berl); 2002 Apr; 80(4):219-32. PubMed ID: 11976731 [TBL] [Abstract][Full Text] [Related]
17. Imatinib: the promise of a "magic bullet" for cancer fulfilled. Henderson CA J Med Assoc Ga; 2003; 92(1):12-4, 22. PubMed ID: 12743899 [No Abstract] [Full Text] [Related]